One recent reviewed article showed a trend toward more death and major adverse cardiovascular events in PFA-100-defined aspirin non-responders.
1
—
—
One recent reviewed article showed a trend toward more death and major adverse cardiovascular events in PFA-100-defined aspirin non-responders.